Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Masayuki Kamochi is active.

Publication


Featured researches published by Masayuki Kamochi.


Transfusion | 2002

Profound ionized hypomagnesemia induced by therapeutic plasma exchange in liver failure patients

Masayuki Kamochi; Keiji Aibara; Koichi Nakata; Masahiro Murakami; Koichiro Nandate; Hisahiro Sakamoto; Takeyoshi Sata; Akio Shigematsu

BACKGROUND : Various adverse effects, including cardiac arrest, have been induced by plasma exchange (PE). Electrolyte derangement is frequently observed. The purpose of this study was to assess the effect of PE on the serum ionized magnesium (Mg 2+ ) concentration in acute liver failure patients.


JMM Case Reports | 2017

The first fatal case of Corynebacterium ulcerans infection in Japan

Ken Otsuji; Kazumasa Fukuda; Takeru Endo; Satoko Shimizu; Nobuya Harayama; Midori Ogawa; Akihiko Yamamoto; Kaoru Umeda; Toshiyuki Umata; Hiroyuki Seki; Masaaki Iwaki; Masayuki Kamochi; Mitsumasa Saito

Introduction. Corynebacterium ulcerans (C. ulcerans) is a zoonotic pathogen that occasionally causes diphtheria-like symptoms in humans. Cases of C. ulcerans infection have been increasing in recent years, and C. ulcerans has been recognized as an emerging pathogen. Case presentation. Here we report a case of asphyxia death due to pseudomembrane caused by diphtheria toxin (DT)-producing C. ulcerans. This is, to our knowledge, the first fatal case of C. ulcerans infection in Japan. A strain of C. ulcerans was obtained from the patient’s pet cat and was confirmed to be identical to the patient’s isolate by sequencing of the 16S rRNA gene and the DT gene, by pulsed-field gel electrophoresis (PFGE) and by ribotyping. In the same way, it was revealed that the isolate in this case belonged to the same molecular type as the C. ulcerans 0102 isolated from the first case in Japan in a distant prefecture 15 years earlier, in 2001. Conclusion. DT-producing C. ulcerans can be contracted from a companion animal and causes human death if the appropriate treatment is delayed. The finding indicates that this molecular type of virulent C. ulcerans is currently widespread in Japan.


Journal of UOEH | 2018

Usefulness of Fibrinogen/Fibrin Degradation Products Value in Differential Diagnosis Between Acute Ischemic Stroke and Acute Aortic Dissection

Shun-ichi Nihei; Hideaki Arai; Takayuki Uchida; Ayako Kanazawa; Takeru Endo; Ken Otsuji; Nobuya Harayama; Keiji Aibara; Masayuki Kamochi

A post-marketing surveillance study reported fatalities following tissue plasminogen activator administration in acute aortic dissection (AAD) with the symptoms of acute ischemic stroke (AIS) patients. Therefore, it is important to discriminate AAD from AIS. The present study aimed to investigate whether fibrinogen/fibrin degradation products (FDP) value can be useful in differential diagnosis between AAD and AIS. The study group comprised 20 AAD patients (10 men and 10 women; age 63.9 ± 13.6 years) and 159 AIS patients (91 men and 68 women; age 74.2 ± 10.6 years) who were transported to our hospital from 2007 to 2012. The AAD cases were further divided into patent-type AAD and thrombosed-type AAD. FDP values were significantly higher in the AAD group than in the AIS group (18.15 [5.2 - 249.9] μg/ml vs. 2.3 [1.5 - 4.45] μg/ml ; P < 0.001). In AAD groups, FDP values were significantly higher in the patent-type AAD group (n = 9) than in the thrombosed type AAD group (n = 11) (293.2 μg/ml [63.1 - 419.6 μg/ml ] vs. 5.6 μg/ml [3.8 - 7.9 μg/ml ]. FDP values were significantly higher in patients with AAD than in those with AIS, especially those with patent-type AAD compared with AIS patients. High FDP values may be a useful marker for differential diagnosis between patent-type AAD and AIS.


Journal of UOEH | 2017

A Case of Infectious Enterocolitis with Hyperammonemia

Ken Otsuji; Satoko Simizu; Takeru Endo; Ayako Kanazawa; Hideaki Arai; Keiji Nagata; Nobuya Harayama; Shun-ichi Nihei; Keiji Aibara; Mitsumasa Saito; Masayuki Kamochi

Case reports of hyperammonemia due to urease-producing bacteria are found occasionally, but most of them are associated with urinary tract infections. We experienced a case of infectious enterocolitis with hyperammonemia in which the causative bacteria was speculated to be urease-producing bacteria. A Japanese woman in her 70s had been diagnosed with microscopic polyangiitis in a nearby hospital and was transferred to our hospital. Although the microscopic polyangiitis was relatively under control after treatment with steroids and rituximab, frequent diarrhea with hyperammonemia (324 µg/dl) appeared and she became comatose. Her blood ammonia decreased to 47 µg/dl and her consciousness recovered to a normal state after antibiotic treatment for infectious enterocolitis and ammonia detoxification therapy. Liver dysfunction, portosystemic shunt, excessive protein intake and constipation were not observed, and she took no medications that would cause hyperammonemia. Although culture results could not identify urease-producing bacteria, considering the clinical course, acute hyperammonemia was suspected to be due to urease-producing bacteria infection. It is necessary to consider the influence of urease-producing bacteria as a cause of acute hyperammonemia not only in urinary tract infections but also in infective enterocolitis.


Journal of UOEH | 2016

[Drug Therapy for Shock-Resistant Ventricular Fibrillation: Comparison of Nifekalant and Amiodarone].

Nobuya Harayama; Shun-ichi Nihei; Keiji Nagata; Keiji Aibara; Masayuki Kamochi; Takeyoshi Sata

Early direct current (DC) shock is the most important therapy for ventricular fibrillation. Following the increased availability of automated external defibrillators (AED), the survival rate of cardiopulmonary arrest patients with ventricular fibrillation has improved. Although patients with shock-resistant ventricular fibrillation require additional antiarrhythmic drug therapy, the optimal protocol has not been established. Nifekalant is a pure potassium channel blocker with a pyrimidinedione structure. Nifekalant was approved in Japan for the treatment of life-threatening ventricular tachyarrhythmias in 1999, and is widely used as a class III antiarrhythmic intravenous drug. Intravenous amiodarone was approved in Japan in 2007, and exhibits various effects on ion channels, receptors, sympathetic activity, and thyroid function. Nifekalant and amiodarone also exhibit many pharmacological and pharmacodynamic differences. As nifekalant has no negative inotropic effect and a rapid action and clearance with a short half-life, it has some advantages over amiodarone for use in cardiopulmonary resuscitation. Indeed, data from clinical and animal studies suggest that nifekalant is superior to amiodarone for resuscitation of cardiopulmonary arrest resulting from shock-resistant ventricular fibrillation. A 300-mg bolus intravenous injection of amiodarone is considered an overdose for resuscitation of shock-resistant ventricular fibrillation. Further clinical studies are required to evaluate the effects of nifekalant compared with amiodarone, and to determine the optimal dose of amiodaone, for resuscitation of shock-resistant ventricular fibrillation.


Acute medicine and surgery | 2015

Press‐through package mis‐swallowing: Usefulness of computed tomography

Ayako Kanazawa; Fumihiko Kamezaki; Takashi Kido; Seigen Yamasaki; Kazuki Someya; Tatsuo Takama; Hiroki Otsubo; Ichiro Yoshikawa; Masayuki Kamochi; Toshihiko Mayumi

An 88‐year‐old female with Alzheimers‐type dementia who mis‐swallowed a press‐through package visited our emergency department.


Journal of UOEH | 2003

[Guidelines for revised cardiopulmonary resuscitation--basic life support].

Koichiroh Nandate; Masahiro Murakami; Keiji Aibara; Masayuki Kamochi

Basic life support(BLS) does not require any special instruments or drugs, and its skills can be understood and performed easily by the lay person. The main goal of cardiopulmonary resuscitation(CPR) for the victims of cardiac pulmonary arrest(CPA) is not only restoration of cardiopulmonary function but also return to their previous life. An early bystander CPR plays a pivotal role to achieve this target. When encountering an unconscious person, emergency medical systems(EMS) such as calling 119 must be activated immediately. As the next step, cardiopulmonary condition status has to be determined after assurance of airway patency. When there are no signs of breathing or pulse, BLS consisting of artificial respiration and/or chest compression must be started immediately and continued until EMS staffs arrive. In this article, the details of the revised guidelines for BLS by the American Heart Association are described. Current CPR education for pre- or early post-graduate medical students in our institution is reported.


American Journal of Kidney Diseases | 2002

Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock

Kohei Uriu; Akihiko Osajima; Kinya Hiroshige; Hiroyuki Watanabe; Keiji Aibara; Yoshifumi Inada; Kayoko Segawa; Hiroshi Anai; Ichiro Takagi; Aki Ito; Masayuki Kamochi; Kazo Kaizu


Infection and Immunity | 1993

An antagonist of platelet-activating factor suppresses endotoxin-induced tumor necrosis factor and mortality in mice pretreated with carrageenan.

Masanori Ogata; Takahiro Matsumoto; K. Koga; I. Takenaka; Masayuki Kamochi; T. Sata; Shin-ichi Yoshida; Akio Shigematsu


Infection and Immunity | 1992

Protective effects of a leukotriene inhibitor and a leukotriene antagonist on endotoxin-induced mortality in carrageenan-pretreated mice.

Masanori Ogata; Takahiro Matsumoto; Masayuki Kamochi; Shin-ichi Yoshida; Y. Mizuguchi; Akio Shigematsu

Collaboration


Dive into the Masayuki Kamochi's collaboration.

Top Co-Authors

Avatar

Keiji Aibara

University of Occupational and Environmental Health Japan

View shared research outputs
Top Co-Authors

Avatar

Nobuya Harayama

University of Occupational and Environmental Health Japan

View shared research outputs
Top Co-Authors

Avatar

Shun-ichi Nihei

University of Occupational and Environmental Health Japan

View shared research outputs
Top Co-Authors

Avatar

Keiji Nagata

University of Occupational and Environmental Health Japan

View shared research outputs
Top Co-Authors

Avatar

Akio Shigematsu

University of Occupational and Environmental Health Japan

View shared research outputs
Top Co-Authors

Avatar

Yasuki Isa

University of Occupational and Environmental Health Japan

View shared research outputs
Top Co-Authors

Avatar

Takeyoshi Sata

University of Occupational and Environmental Health Japan

View shared research outputs
Top Co-Authors

Avatar

Hideaki Arai

University of Occupational and Environmental Health Japan

View shared research outputs
Top Co-Authors

Avatar

Ayako Kanazawa

University of Occupational and Environmental Health Japan

View shared research outputs
Top Co-Authors

Avatar

Hiroyuki Matsumoto

University of Occupational and Environmental Health Japan

View shared research outputs
Researchain Logo
Decentralizing Knowledge